Roelof Rongen
2018
In 2018, Roelof Rongen earned a total compensation of $400K as Former Chief Executive Officer at Matinas BioPharma Holdings, a 79% decrease compared to previous year.
Compensation breakdown
| Salary | $183,333 |
|---|---|
| Other | $216,667 |
| Total | $400,000 |
Rongen received $216.7K in other compensation, accounting for 54% of the total pay in 2018.
Rongen also received $183.3K in salary.
Rankings
In 2018, Roelof Rongen's compensation ranked 12,541st out of 14,244 executives tracked by ExecPay. In other words, Rongen earned more than 12.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,541 out of 14,244 | 12th |
Division Manufacturing | 5,071 out of 5,758 | 12th |
Major group Chemicals And Allied Products | 1,918 out of 2,119 | 10th |
Industry group Drugs | 1,642 out of 1,808 | 9th |
Industry Pharmaceutical Preparations | 1,256 out of 1,382 | 9th |
Source: SEC filing on September 24, 2019.
Rongen's colleagues
We found four more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2018.
2018
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
2018
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
2018
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
2018
Gary Gaglione
Matinas BioPharma Holdings